Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

An Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Chinese Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

Astellas (Beijing) Pharmaceutical R&D Co., Ltd. · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
metastatic hormone sensitive prostate cancer, androgen deprivation therapy (adt), xtandi, mdv3100, enzalutamide, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 966465
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.